Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Jones

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
The Plant Cell|February 25, 2017
RETRACTED: The Cf-9 Disease Resistance Protein Is Present in an ∼420-Kilodalton Heteromultimeric Membrane-Associated Complex at One Molecule per ComplexSusana Rivas, Tina Romeis, Jonathan D Jones
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|November 22, 2011
Crystallization and preliminary X-ray analysis of the RXLR-type effector RXLR3 from the oomycete pathogen Hyaloperonospora arabidopsidisLennart Wirthmueller, Jonathan D Jones, Mark J Banfield
Musculoskeletal Care|February 26, 2025
The Movement, Mindfulness, and Pain Science (MMaPS) Class Improves Well-Being and Physical Function in Patients With Chronic PainSharna Prasad, Olivia Coskey, Micah Wong, et al.
Rheumatology International|August 11, 2020
Comparing quality and readability of online English language information to patient use and perspectives for common rheumatologic conditionsRyan D Willen, Olivia Pipitone, Syna Daudfar, et al.
Arthritis and Rheumatism|January 22, 2013
Reply: To PMID 22674374Jonathan D Jones, B JoNell Hamilton, William F C Rigby
Journal of Autoimmunity|November 5, 2017
"NETtling" the host: Breaking of tolerance in chronic inflammation and chronic infectionSladjana Skopelja-Gardner, Jonathan D Jones, William F C Rigby
Arthritis and Rheumatism|June 8, 2012
Rituximab mediates loss of CD19 on B cells in the absence of cell deathJonathan D Jones, B JoNell Hamilton, William F C Rigby
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2017
Editorial: Anti-Citrullinated Protein Antibody, Anti-Carbamylated Protein Antibody, and Rheumatoid Arthritis: Azurophilic Granules Sing the BluesWilliam F C Rigby, Sladjana Skopelja-Gardner, Jonathan D Jones
Clinical Rheumatology|May 23, 2016
Rituximab associated late-onset neutropenia-a rheumatology case series and review of the literatureWilliam E Monaco, Jonathan D Jones, William F C Rigby
Arthritis & Rheumatology (Hoboken, N.J.)|March 16, 2017
Brief Report: Anti-Carbamylated Protein Antibodies in Rheumatoid Arthritis Patients Are Reactive With Specific Epitopes of the Human Fibrinogen β-ChainJonathan D Jones, B JoNell Hamilton, William F C Rigby
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
The Plant Cell|February 25, 2017
RETRACTED: The Cf-9 Disease Resistance Protein Is Present in an ∼420-Kilodalton Heteromultimeric Membrane-Associated Complex at One Molecule per ComplexSusana Rivas, Tina Romeis, Jonathan D Jones
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|November 22, 2011
Crystallization and preliminary X-ray analysis of the RXLR-type effector RXLR3 from the oomycete pathogen Hyaloperonospora arabidopsidisLennart Wirthmueller, Jonathan D Jones, Mark J Banfield
Musculoskeletal Care|February 26, 2025
The Movement, Mindfulness, and Pain Science (MMaPS) Class Improves Well-Being and Physical Function in Patients With Chronic PainSharna Prasad, Olivia Coskey, Micah Wong, et al.
Rheumatology International|August 11, 2020
Comparing quality and readability of online English language information to patient use and perspectives for common rheumatologic conditionsRyan D Willen, Olivia Pipitone, Syna Daudfar, et al.
Arthritis and Rheumatism|January 22, 2013
Reply: To PMID 22674374Jonathan D Jones, B JoNell Hamilton, William F C Rigby
Journal of Autoimmunity|November 5, 2017
"NETtling" the host: Breaking of tolerance in chronic inflammation and chronic infectionSladjana Skopelja-Gardner, Jonathan D Jones, William F C Rigby
Arthritis and Rheumatism|June 8, 2012
Rituximab mediates loss of CD19 on B cells in the absence of cell deathJonathan D Jones, B JoNell Hamilton, William F C Rigby
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2017
Editorial: Anti-Citrullinated Protein Antibody, Anti-Carbamylated Protein Antibody, and Rheumatoid Arthritis: Azurophilic Granules Sing the BluesWilliam F C Rigby, Sladjana Skopelja-Gardner, Jonathan D Jones
Clinical Rheumatology|May 23, 2016
Rituximab associated late-onset neutropenia-a rheumatology case series and review of the literatureWilliam E Monaco, Jonathan D Jones, William F C Rigby
Arthritis & Rheumatology (Hoboken, N.J.)|March 16, 2017
Brief Report: Anti-Carbamylated Protein Antibodies in Rheumatoid Arthritis Patients Are Reactive With Specific Epitopes of the Human Fibrinogen β-ChainJonathan D Jones, B JoNell Hamilton, William F C Rigby
Pageof 3